| Yan Yan, MD | |
|
1860 El Camino Real Ste 50, Burlingame, CA 94010-3100 | |
| (650) 651-3668 | |
| (650) 948-4993 |
| Full Name | Yan Yan |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 18 Years |
| Location | 1860 El Camino Real Ste 50, Burlingame, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154663771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A141993 (California) | Primary |
| Entity Name | North East Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093992844 PECOS PAC ID: 4284520529 Enrollment ID: O20040224001157 |
News Archive
The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.
Noting "multidrug-resistant organisms are showing up in top-flight hospitals" around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, "What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones."
Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease.
› Verified 3 days ago
| Entity Name | Columbia Asthma & Allergy Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962687566 PECOS PAC ID: 4688606536 Enrollment ID: O20090904000403 |
News Archive
The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.
Noting "multidrug-resistant organisms are showing up in top-flight hospitals" around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, "What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones."
Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease.
› Verified 3 days ago
| Entity Name | Beautiful Life Wellness |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154049948 PECOS PAC ID: 0446625347 Enrollment ID: O20230406001325 |
News Archive
The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.
Noting "multidrug-resistant organisms are showing up in top-flight hospitals" around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, "What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones."
Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yan Yan, MD 1860 El Camino Real Ste 50, Burlingame, CA 94010-3100 Ph: (650) 651-3668 | Yan Yan, MD 1860 El Camino Real Ste 50, Burlingame, CA 94010-3100 Ph: (650) 651-3668 |
News Archive
The discovery of faulty genes by Edinburgh researchers could help people with Paget's disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.
Omega Healthcare Investors, Inc., announced today that its Board of Directors has authorized the repurchase of up to $100 million of its outstanding common stock, from time to time over the next 12 months.
Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.
Noting "multidrug-resistant organisms are showing up in top-flight hospitals" around the world, Carl Nathan, chair of the department of microbiology and immunology at Weill Cornell Medical College, writes in this New York Times opinion piece, "What makes the rapid loss of antibiotics to drug resistance particularly alarming is that we are failing to make new ones."
Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease.
› Verified 3 days ago
Dr. Barbara Conner-andersen, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1828 El Camino Real, Suite 703, Burlingame, CA 94010 Phone: 650-692-1892 Fax: 650-692-5493 | |
Dr. Eugene Y Choi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2849 Mariposa Dr, Burlingame, CA 94010 Phone: 650-692-6543 Fax: 650-692-6543 | |
Dr. Margaret Delano, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1828 El Camino Real, Suite 703, Burlingame, CA 94010 Phone: 650-692-1892 Fax: 650-692-5493 |